Gino A Cortopassi

Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers.

D. Bell, Y. Liu, G. Cortopassi, 1995, Journal of the National Cancer Institute.

Altered Toxicological Endpoints in Humans with Quaternary Ammonium Compound Exposure

G. Cortopassi, R. T. Williams, T. Hrubec, 2020, medRxiv.

Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.

G. Cortopassi, D. Thompson, B. Hammock, 2001, Archives of biochemistry and biophysics.

Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria.

E. Wang, D. Bredesen, G. Fiskum, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Frequencies of hprt(-) mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records.

Y. Liu, G. Cortopassi, M. Green, 1999, Mutagenesis.

Using the polymerase chain reaction to estimate mutation frequencies and rates in human cells.

N. Arnheim, G. Cortopassi, Gino A Cortopassi, 1992, Mutation research.

Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells

M. Savontaus, Heather E. Collins-Schramm, Michael F. Seldin, 2002 .

Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN6 sensitizes cisplatin lung anticancer therapy due to a remodeling of energy metabolism.

V. Sardão, R. Amorim, F. Cagide, 2023, Biochemical pharmacology.